Skip NavigationSkip to Content
Return Return to Search Results

Interleukin 18 (IL-18) in synergy with IL-2 induces lethal lung injury in mice: A potential role for cytokines, chemokines, and natural killer cells in the pathogenesis of interstitial pneumonia

  1. Author:
    Okamoto, M.
    Kato, S.
    Oizumi, K.
    Kinoshita, M.
    Inoue, Y.
    Hoshino, K.
    Akira, S.
    McKenzie, A. N. J.
    Young, H. A.
    Hoshino, T.

  2. Author Address

    Kurume Univ, Sch Med, Dept Internal Med 1, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan. Kurume Univ, Sch Med, Dept Internal Med 1, Kurume, Fukuoka 8300011, Japan. Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka 8300011, Japan. Nippon Organon, Div Res & Dev, R&D Labs, Osaka, Japan. Osaka Univ, Res Inst Microbial Dis, Dept Host Def, Suita, Osaka 565, Japan. Japan Sci & Technol Corp, CREST, Suita, Osaka, Japan. MRC, Mol Biol Lab, Cambridge CB2 2QH, England. NCI, Expt Immunol Lab, Frederick, MD 21701 USA. Hoshino T Kurume Univ, Sch Med, Dept Internal Med 1, 67 Asahi Machi, Kurume, Fukuoka 8300011, Japan.
    1. Year: 2002
  2. Journal: Blood
    1. 99
    2. 4
    3. Pages: 1289-1298
  4. Type of Article: Article
  1. Abstract:

    Interleukin 18 (IL-18) was discovered as an interferon-gamma (IFN-gamma)-inducing factor and plays important roles in natural killer (NK) cell activation. IL-18 also induces proinflammatory cytokines; chemokines; helper T-cell 2 (T(H)2) cytokines (eg, IL-4, IL-13); and immunoglobulin E (Ig-E) and IgG1 production. The combination of IL-18 plus IL-2 or IL-12 up-regulates IFN-gamma gene expression and NK cytotoxicity and has synergistic antitumor activity in vivo and in vitro. Here it is reported that daily administration of IL-18 with IL-2, but not of IL-18 or IL-2 alone, induces lethal lung injury in normal mice, but not in IL-18 receptor alpha (IL-1 receptor- related protein)-deficient (IL-18 receptor alpha(-/-)) mice. Marked interstitial infiltration of lymphocytes, composed mainly of NK cells, was found in the lungs of IL-18/IL-2- treated mice. Increased cytokine and chemokine levels were observed in the sera and lungs of IL-18/IL-2-treated mice. Administration of IL-18/IL-2 was also lethal to mice treated with a metalloproteinase inhibitor, which inhibited tumor necrosis factor-alpha and Fas-ligand release. While IFN-gamma(- /-) mice were partially resistant to the treatment, IL-4(-/-), IL-13(-/-), IL-4/IL-13(-/-), and Stat6(-/-) mice were sensitive, to IL-18/IL-2, indicating that these genes were not involved in the host response. The lethal effect by IL-18/IL-2 was completely eliminated in severe combined immunodeficient mice pretreated with antiasialo-GM1 antibody and normal mice pretreated with anti-NK1.1 but not with anti-CD4 or anti-CD8, monoclonal antibody. These results suggest that specific cytokines, chemokines, and NK cells are involved in the pathogenesis of interstitial pneumonia. These results suggest that the clinical use of this interleukin may result in unexpected physiological consequences. (C) 2002 by The American Society of Hematology.

    See More

  1. Keywords:

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel